Skip to content
BioMedsAI

Legal

Disclaimers

All BioMedsAI analyses, reports, software outputs and communications are provided for research use only and are not for use in diagnostic procedures. BioMedsAI, Inc. is not a CLIA-certified laboratory and does not perform clinical testing. BioMedsAI is not a notified body and holds no accreditation for conformity assessment. Evaluations are independent scientific opinions, not regulatory determinations.

Where BioMedsAI coordinates sequencing or other laboratory experiments, they are performed by qualified third-party laboratories under their own accreditations; BioMedsAI operates no wet laboratory and generates no sequencing data itself.

Subject-matter specialists offering consultations through the platform give their own professional opinions for research use; they do not provide medical advice.

Measurable-residual-disease (MRD) analyses are research-grade analyses with explicit limit-of-detection reporting. They are not clinical MRD tests and must not be used to guide patient care.

Padma and other AI can make mistakes

Padma, our AI scientist, and the other automated parts of the platform can make mistakes. They can misread a sample sheet, choose an unsuitable method or setting, miss a problem in the data, state something with more confidence than the evidence allows, or cite a source incorrectly. Every result, figure, interpretation, citation and draft text is a starting point for your own scientific judgement: check it before you rely on it, and before you publish, present or share it.

For work where an error would be costly (a manuscript, a grant, a regulatory or translational decision, or an unusual study design), we encourage a scientist-led project, in which a BioMedsAI scientist designs, checks and signs off the analysis with you.

Offers, discounts and "The $100,000 Surprise"

"The $100,000 Surprise" is our thank-you to the scientific community: BioMedsAI puts up to US$100,000 in total into discounts on its packages, from the Week pass to yearly plans, while the offer lasts. It is a commercial discount, not a sweepstakes, prize or contest; there is no draw and no element of chance.

Incidents and the limits of our responsibility

The platform runs on third-party cloud, computing, payment and email services and on open-source software. Analyses can fail, queue for longer than estimated or be interrupted; services can be unavailable; and, despite our safeguards, data can be delayed, corrupted or lost. To the fullest extent permitted by law, BioMedsAI is not responsible for unexpected incidents or their consequences, including outages and interruptions, delays, failed or incomplete analyses, loss or corruption of data, errors in AI or software outputs, actions of third-party providers, or decisions you make based on any output. Our responsibility is limited as set out in our Terms of use.

Keep your own copies of your data and download the results you need while your package is active; when a package ends, the workspace closes until you continue.

Safe and responsible use

Data shown on this website

* Public dataset: GEO accession GSE244589, single-cell RNA-seq of peripheral blood from 5 patients with essential thrombocythemia (ET), a myeloproliferative neoplasm (MPN), and 3 healthy donors (He et al., J Clin Invest 2024; doi:10.1172/JCI172256). Reanalysed by Padma. Research use only; not a clinical result.

Other figures on this website are illustrations unless their caption names a dataset.

Some services are under development; contact us for details. Prices are optimized based on the services available.

Trademarks and programs

© 2026 NVIDIA, the NVIDIA logo, BioNeMo, CUDA, and NVIDIA Inception are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. BioMedsAI’s membership in the NVIDIA Inception program does not mean that NVIDIA endorses BioMedsAI’s products or services. Google Cloud and Google for Startups are trademarks of Google LLC. Stripe and the Stripe logo are trademarks of Stripe, Inc. Other names are trademarks of their owners and are used only to describe programs we take part in and technology we use.

Nothing on this website is an offer to sell securities or a quotation; every engagement is scoped and quoted in writing.